Index Overview

KEDI U.S. Next Tech TOP10 Index

Recent Events

Index Value2,740.426160.866(6.24%)

TickerKUNTT10

BloombergKUNTT10

CurrencyUSD

PublishedAug 6, 2025

Licensed ETFSHINHAN SOL US NEXT TECH TOP10 ACTIVE ETF

Total AUM$34.8M

TickerKUNTT10

BloombergKUNTT10

CurrencyUSD

PublishedAug 6, 2025

Licensed ETFSHINHAN SOL US NEXT TECH TOP10 ACTIVE ETF

Total AUM$34.8M

Recent Key Events

View all

Cogent Biosciences Inc (COGT)

12/30/2026

The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of December 30, 2026, for a decision on the approval of bezuclastinib for NonAdvanced Systemic Mastocytosis (NonAdvSM), scheduled. High importance is estimated as FDA approval decisions for lead assets typically result in ≥10% price impact.

Other

Description

Performance Comparison

Return by Period

Last updated: 4/17/2026

1 Month

10.80%

3 Months

-14.21%

1 Year

86.87%

3 Years

138.99%

Dividend & Premium

Loading dividend & premium...

Latest Top 10 Holdings

Industry Exposure

Detail:

Documents

Index Value (Last 3 Months)